Weekly Recap: LEQSELVI fits US guidance and Taro ER launched in Canada

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) is advancing treatments as LEQSELVI (deuruxolitinib) aligns with new US guidance for severe alopecia areata while it launched Taro-Methylphenidate ER in Canada, and shares rose ~2% with Geojit maintaining a Buy and Rs 2,070 target.Previous Week…